TYVERB Side Effects

7022851-X | Gastrointestinal Toxicity, Renal Failure Acute
on Sep 23, 2010 Female patient from SPAIN , 60 years of age, weighting 169.8 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal toxicity, renal failure acute. Tyverb dosage: . Patient was hospitalized.

7022848-X | Gastrointestinal Toxicity, Renal Failure Acute
Patient was taking Tyverb (View Usage). Patient had the following side effects: gastrointestinal toxicity, renal failure acute on Sep 23, 2010 from SPAIN Additional patient health information: Female patient , 60 years of age, weighting 169.8 lb, was diagnosed with breast cancer (What is breast cancer?) and. Tyverb dosage: . Patient was hospitalized.

7012836-1 | Diarrhoea, Skin Toxicity
Adverse event was reported on Sep 16, 2010 by a Male patient taking Tyverb (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: CZECH REPUBLIC , 28 years of age, After Tyverb was administered, patient had the following side effects: diarrhoea, skin toxicity. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

7012828-2 | Abdominal Pain, Hyperbilirubinaemia, Transaminases Increased
on Sep 16, 2010 Female patient from ITALY , 40 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), hyperbilirubinaemia, transaminases increased. Tyverb dosage: .


7012827-0 | Abdominal Pain, Hyperbilirubinaemia, Transaminases Increased
on Sep 16, 2010 Female patient from ITALY , 34 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), hyperbilirubinaemia, transaminases increased. Tyverb dosage: .

7012823-3 | Dysphagia, Oesophageal Obstruction
Patient was taking Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: dysphagia, oesophageal obstruction on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Tyverb dosage: . Patient was hospitalized.

7005683-8 | Dehydration, Diarrhoea Haemorrhagic, Hypokalaemia, Hyponatraemia
Adverse event was reported on Sep 13, 2010 by a Female patient taking Tyverb (View Usage) (Dosage: ) was diagnosed with breast cancer stage iv and. Location: SPAIN , 53 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea haemorrhagic, hypokalaemia, hyponatraemia. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6985513-0 | Haematotoxicity, Nausea, Neurotoxicity, Skin Toxicity
on Sep 07, 2010 Female patient from CZECH REPUBLIC , 47 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). Patient had the following side effects: haematotoxicity, nausea (What is nausea?), neurotoxicity, skin toxicity. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (2000mgm2 Per Day) (View Xeloda Review and Xeloda Label ), LOW MOLECULAR HEPARIN (View Low Molecular Heparin Review and Low Molecular Heparin Label ).

6985511-7 | Abdominal Pain Upper, Haematotoxicity, Nausea, Neurotoxicity, Skin Toxicity
on Sep 07, 2010 Female patient from CZECH REPUBLIC , 61 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: abdominal pain upper, haematotoxicity, nausea (What is nausea?), neurotoxicity, skin toxicity. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (2000mgm2 Per Day) (View Xeloda Review and Xeloda Label ).

6973888-8 | Psychotic Disorder
Patient was taking Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: psychotic disorder (What is psychotic disorder?) on Sep 08, 2010 from GERMANY Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with breast cancer (What is breast cancer?), vomiting and. Tyverb dosage: 1000mg Per Day. During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

6925792-9 | Psychotic Disorder
Adverse event was reported on Aug 12, 2010 by a Female patient taking Tyverb (View Usage) (Dosage: ) . Location: GERMANY , 53 years of age, Patient had the following side effects: psychotic disorder (What is psychotic disorder?).

6820090-6 | Asthenia, Dyspnoea, Dyspnoea Exertional, Ejection Fraction Decreased, Metastases To Central Nervous System
on Jun 29, 2010 Female patient from SPAIN , 60 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: asthenia, dyspnoea, dyspnoea exertional, ejection fraction decreased, metastases to central nervous system. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), LETROZOLE (View Letrozole Review and Letrozole Label ).

6764197-0 | Fatigue
on Jun 02, 2010 Female patient from BELGIUM , weighting 168.7 lb, was diagnosed with elevated mood, prophylaxis, back pain (What is back pain?) and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with CAPECITABINE (1500mgm2 Per Day) (View Capecitabine Review and Capecitabine Label ), EFFEXOR XR (37.5mg Per Day) (View Effexor Xr Review and Effexor Xr Label ), ALPRAZOLAM (1mg Per Day) (View Alprazolam Review and Alprazolam Label ), DAFALGAN (1g Per Day) (View Dafalgan Review and Dafalgan Label ), OMEPRAZOLE (20mg Per Day) (View Omeprazole Review and Omeprazole Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CONTRAMAL (50mg Per Day) (View Contramal Review and Contramal Label ).

6728210-9 | Enophthalmos, Lipoatrophy
Patient was taking Tyverb (View Usage). Patient had the following side effects: enophthalmos, lipoatrophy on May 13, 2010 from GERMANY Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with breast cancer (What is breast cancer?) and. Tyverb dosage: 250mg Five Times Per Day. During the same period patient was treated with XELODA (1000mg Twice Per Day) (View Xeloda Review and Xeloda Label ), ZOMETA (4mg Monthly) (View Zometa Review and Zometa Label ).

6728204-3 | Dehydration, Diarrhoea
Adverse event was reported on May 11, 2010 by a Female patient taking Tyverb (View Usage) (Dosage: 1250mg Per Day) . Location: SPAIN , 76 years of age, After Tyverb was administered, patient had the following side effects: dehydration, diarrhoea. During the same period patient was treated with LETROZOLE (2.5mg Per Day) (View Letrozole Review and Letrozole Label ). Patient was hospitalized.

6726394-X | Diarrhoea, Hyperbilirubinaemia, Jaundice
on May 07, 2010 Female patient from NORWAY , 39 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hyperbilirubinaemia, jaundice (What is jaundice?). Tyverb dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6626131-3 | Meningism, Metastases To Meninges, Paraneoplastic Syndrome
on Mar 08, 2010 Female patient from GERMANY , weighting 176.4 lb, was treated with Tyverb (View Usage). Patient had the following side effects: meningism, metastases to meninges, paraneoplastic syndrome. Tyverb dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTOSTATICS (View Cytostatics Review and Cytostatics Label ). Patient was hospitalized.

6612086-4 | Infection, Onychomycosis, Superinfection
Patient was taking Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: infection (What is infection?), onychomycosis, superinfection on Feb 23, 2010 from ROMANIA Additional patient health information: Female patient , 53 years of age, . Tyverb dosage: 1250mg Per Day. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6610773-5 | Beta Haemolytic Streptococcal Infection, Paronychia, Staphylococcal Infection
Adverse event was reported on Feb 23, 2010 by a Female patient taking Tyverb (View Usage) (Dosage: 1250mg Per Day) . Location: UNITED KINGDOM , 43 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: beta haemolytic streptococcal infection, paronychia, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), LETROZOLE (View Letrozole Review and Letrozole Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

6457099-0 | Asthenia, Disease Progression, Palmar-plantar Erythrodysaesthesia Syndrome, Rash, Skin Discolouration
on Nov 18, 2009 Female patient from PORTUGAL , 39 years of age, was treated with Tyverb (View Usage). Patient had the following side effects: asthenia, disease progression, palmar-plantar erythrodysaesthesia syndrome, rash (What is rash?), skin discolouration. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

6430681-2 | Acute Respiratory Distress Syndrome
on Nov 04, 2009 Female patient from GERMANY , weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: acute respiratory distress syndrome. Tyverb dosage: .

6400103-6 | Pulmonary Embolism
Patient was taking Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Oct 09, 2009 from FINLAND Additional patient health information: Female patient , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6379450-2 | Breast Cancer Metastatic, Hepatic Enzyme Increased, Hepatitis
Adverse event was reported on Sep 22, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: ) . Location: SWITZERLAND , weighting 165.3 lb, Patient had the following side effects: breast cancer metastatic, hepatic enzyme increased, hepatitis (What is hepatitis?). During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), SINTROM (View Sintrom Review and Sintrom Label ), ATENOLOL (25mg Per Day) (View Atenolol Review and Atenolol Label ).

6377248-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Chromaturia, Fatigue, Hepatotoxicity, Jaundice
on Sep 21, 2009 Female patient from FRANCE , 35 years of age, was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chromaturia, fatigue, hepatotoxicity, jaundice (What is jaundice?). Tyverb dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6356518-8 | Myocardial Infarction
on Sep 07, 2009 Female patient from BELGIUM , 67 years of age, was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Tyverb dosage: . Patient was hospitalized.

6343765-4 | Cerebral Haemorrhage, Diarrhoea, Pulmonary Haemorrhage, Rash, Skin Reaction, Stomatitis
Patient was taking Tyverb (View Usage). Patient had the following side effects: cerebral haemorrhage, diarrhoea, pulmonary haemorrhage, rash (What is rash?), skin reaction, stomatitis on Aug 28, 2009 from AUSTRIA Additional patient health information: Female patient , 67 years of age, weighting 127.9 lb, was diagnosed with metastases to central nervous system, breast neoplasm, metastases to bone and. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (3000mg Per Day) (View Xeloda Review and Xeloda Label ), LIDOCAINE (2000mgm2 Per Day) (View Lidocaine Review and Lidocaine Label ), FEMARA (1tab Per Day) (View Femara Review and Femara Label ), THYREX (View Thyrex Review and Thyrex Label ), FORTECORTIN (4mg Per Day) (View Fortecortin Review and Fortecortin Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

6339336-6 | Dehydration, Diarrhoea, Hyponatraemia, Lipase Increased, Malaise, Orthostatic Hypotension, Pancreatitis, Renal Failure, Skinfold Measurement
Adverse event was reported on Aug 25, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: 1250mg Per Day) was diagnosed with breast cancer metastatic and. Location: FRANCE , 74 years of age, After Tyverb was administered, patient had the following side effects: dehydration, diarrhoea, hyponatraemia, lipase increased, malaise, orthostatic hypotension, pancreatitis, renal failure, skinfold measurement. During the same period patient was treated with XELODA (1500mg Cyclic) (View Xeloda Review and Xeloda Label ), ZOMETA (4mg Monthly) (View Zometa Review and Zometa Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ), INEXIUM (View Inexium Review and Inexium Label ). Patient was hospitalized.

6332776-0 | Breast Cancer, Metastases To Liver, Muscular Weakness, Oedema Peripheral, Skin Lesion
on Aug 21, 2009 Female patient from LATVIA , weighting 132.3 lb, was diagnosed with breast cancer (What is breast cancer?), metastases to liver and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), metastases to liver, muscular weakness, oedema peripheral, skin lesion. Tyverb dosage: 2500mg Per Day. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6294715-0 | Abdominal Pain, Asthenia, Blood Bilirubin Increased, Decreased Appetite, Dehydration, Diarrhoea, Dysphagia, Hypermagnesaemia
on Jul 23, 2009 Female patient from FRANCE , weighting 123.5 lb, was diagnosed with prophylaxis and was treated with Tyverb (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, blood bilirubin increased, decreased appetite, dehydration, diarrhoea, dysphagia, hypermagnesaemia. Tyverb dosage: 2500mg Per Day. During the same period patient was treated with XELODA (1650mg Per Day) (View Xeloda Review and Xeloda Label ), TARKA (View Tarka Review and Tarka Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.

6277767-3 | Cerebral Haemorrhage, Diarrhoea, Pulmonary Haemorrhage, Skin Reaction
Patient was taking Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: cerebral haemorrhage, diarrhoea, pulmonary haemorrhage, skin reaction on Jul 13, 2009 from AUSTRIA Additional patient health information: Female patient , 67 years of age, . Tyverb dosage: 1250mg Per Day. During the same period patient was treated with LIDOCAINE (2000mgm2 Per Day) (View Lidocaine Review and Lidocaine Label ), FEMARA (1tab Per Day) (View Femara Review and Femara Label ), THYREX (View Thyrex Review and Thyrex Label ), FORTECORTIN (4mg Per Day) (View Fortecortin Review and Fortecortin Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

6267359-4 | Breast Cancer, Muscular Weakness, Oedema Peripheral
Adverse event was reported on Jul 06, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: 2500mg Per Day) was diagnosed with breast cancer (What is breast cancer?) and. Location: LATVIA , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), muscular weakness, oedema peripheral. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ).

6261970-2 | Cough, Dyspnoea, Interstitial Lung Disease, Lung Infiltration, Pneumonia Primary Atypical, Pneumonitis, Pyrexia, Rales, Tachypnoea
on Jul 03, 2009 Female patient from GERMANY , weighting 121.3 lb, was diagnosed with breast cancer (What is breast cancer?), pain (What is pain?), constipation prophylaxis and was treated with Tyverb (View Usage). Patient had the following side effects: cough, dyspnoea, interstitial lung disease, lung infiltration, pneumonia primary atypical, pneumonitis, pyrexia, rales, tachypnoea. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ), IBUPROFEN (400mg Three Times Per Day) (View Ibuprofen Review and Ibuprofen Label ), OXYGESIC (10mg Three Times Per Day) (View Oxygesic Review and Oxygesic Label ), NULYTELY (View Nulytely Review and Nulytely Label ), XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6258753-6 |
on Jun 29, 2009 Female patient from LATVIA , 45 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tyverb (View Usage). . Tyverb dosage: 2500mg Per Day. During the same period patient was treated with KYTRIL (View Kytril Review and Kytril Label ).

6258746-9 | Hepatitis Toxic, Interstitial Lung Disease
Patient was taking Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis toxic, interstitial lung disease on Jun 25, 2009 from SPAIN Additional patient health information: Female patient , 38 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Tyverb dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6233021-7 | Anal Pruritus, Anorectal Discomfort, Candidiasis, Rash, Staphylococcal Infection
Adverse event was reported on Jun 15, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: 1250mg Per Day) . Location: IRELAND , weighting 127.0 lb, Patient had the following side effects: anal pruritus, anorectal discomfort, candidiasis, rash (What is rash?), staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with XELODA (1500mg Twice Per Day) (View Xeloda Review and Xeloda Label ), ZOMETA (View Zometa Review and Zometa Label ), EUCERIN (View Eucerin Review and Eucerin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), IDEOS (View Ideos Review and Ideos Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), IMODIUM (View Imodium Review and Imodium Label ), ZOFRON (View Zofron Review and Zofron Label ).

6229650-7 | Anal Pruritus, Anorectal Discomfort, Candidiasis, Rash, Staphylococcal Infection
on Jun 08, 2009 Female patient from IRELAND , weighting 127.0 lb, was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: anal pruritus, anorectal discomfort, candidiasis, rash (What is rash?), staphylococcal infection (What is staphylococcal infection?). Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (1500mg Twice Per Day) (View Xeloda Review and Xeloda Label ), ZOMETA (View Zometa Review and Zometa Label ), EUCERIN (View Eucerin Review and Eucerin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), IDEOS (View Ideos Review and Ideos Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), IMODIUM (View Imodium Review and Imodium Label ), ZOFRON (View Zofron Review and Zofron Label ).

6190381-3 | Anal Pruritus, Anorectal Discomfort, Candidiasis, Rash, Staphylococcal Infection
on May 06, 2009 Female patient from IRELAND , weighting 127.0 lb, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: anal pruritus, anorectal discomfort, candidiasis, rash (What is rash?), staphylococcal infection (What is staphylococcal infection?). Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (1500mg Twice Per Day) (View Xeloda Review and Xeloda Label ), ZOMETA (View Zometa Review and Zometa Label ), EUCERIN (View Eucerin Review and Eucerin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), IDEOS (View Ideos Review and Ideos Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), IMODIUM (View Imodium Review and Imodium Label ), ZOFRON (View Zofron Review and Zofron Label ).

6185896-8 | Palmar-plantar Erythrodysaesthesia Syndrome, Pneumonia
Patient was taking Tyverb (View Usage). Patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome, pneumonia (What is pneumonia?) on May 06, 2009 from GERMANY Additional patient health information: Female patient , weighting 136.7 lb, . Tyverb dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), IMODIUM (View Imodium Review and Imodium Label ). Patient was hospitalized.

6161878-7 | Hypoalbuminaemia, Oedema Peripheral
Adverse event was reported on Apr 16, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: 1250mg Per Day) . Location: FINLAND , 50 years of age, After Tyverb was administered, patient had the following side effects: hypoalbuminaemia, oedema peripheral. During the same period patient was treated with DEXAMETHASONE TAB (1.5mg Twice Per Day) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), THYROXIN (View Thyroxin Review and Thyroxin Label ), EMCONCOR (10mg Per Day) (View Emconcor Review and Emconcor Label ), ZANIDIP (10mg Per Day) (View Zanidip Review and Zanidip Label ), CRESTOR (10mg Per Day) (View Crestor Review and Crestor Label ), COZAAR (100mg Per Day) (View Cozaar Review and Cozaar Label ), TENOX (10mg At Night) (View Tenox Review and Tenox Label ), DIAZEPAM (10mg As Required) (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6158766-9 | Diarrhoea, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome
on Apr 07, 2009 Female patient from RUSSIAN FEDERATION , weighting 126.1 lb, was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome. Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (3000mg Per Day) (View Xeloda Review and Xeloda Label ).

6150036-8 | Diarrhoea, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome
on Apr 03, 2009 Female patient from RUSSIAN FEDERATION , 48 years of age, was treated with Tyverb (View Usage). Patient had the following side effects: diarrhoea, nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome. Tyverb dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

6143317-5 | Deep Vein Thrombosis, Hepatic Function Abnormal, Oedema Peripheral, Pulmonary Embolism, Pulmonary Oedema
Patient was taking Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), hepatic function abnormal, oedema peripheral, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema on Mar 27, 2009 from BELGIUM Additional patient health information: Female patient , weighting 145.3 lb, . Tyverb dosage: 250mg Five Times Per Day. During the same period patient was treated with XELODA (1750mg Twice Per Day) (View Xeloda Review and Xeloda Label ), MEDROL (16mg Per Day) (View Medrol Review and Medrol Label ), ZOMETA (4mg Every 3 Weeks) (View Zometa Review and Zometa Label ).

6119570-0 | Pain, Radiation Skin Injury, Rash, Skin Infection
Adverse event was reported on Mar 12, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: 1500mg Per Day) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: pain (What is pain?), radiation skin injury, rash (What is rash?), skin infection.

6119555-4 | Deep Vein Thrombosis, Hepatic Function Abnormal, Oedema Peripheral, Pulmonary Embolism, Pulmonary Oedema
on Mar 06, 2009 Female patient from BELGIUM , 46 years of age, weighting 145.3 lb, was treated with Tyverb (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), hepatic function abnormal, oedema peripheral, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema. Tyverb dosage: 250mg Five Times Per Day. During the same period patient was treated with XELODA (3500mg Per Day) (View Xeloda Review and Xeloda Label ), MEDROL (16mg Per Day) (View Medrol Review and Medrol Label ), ZOMETA (View Zometa Review and Zometa Label ).

6115054-4 | Dysphagia, Dysuria, Mucosal Inflammation, Palmar-plantar Erythrodysaesthesia Syndrome, Skin Exfoliation
on Mar 04, 2009 Female patient from FRANCE , 55 years of age, weighting 103.6 lb, was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: dysphagia, dysuria, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, skin exfoliation. Tyverb dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6105532-6 | Diarrhoea, Gastrointestinal Toxicity, Mucosal Inflammation
Patient was taking Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, gastrointestinal toxicity, mucosal inflammation on Feb 24, 2009 from FRANCE Additional patient health information: Female patient , 67 years of age, . Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6103936-9 | Cystitis, Decreased Appetite, Diarrhoea, Herpes Zoster, Nausea, Oedema Peripheral, Pain, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Feb 24, 2009 by a Female patient taking Tyverb (View Usage) (Dosage: ) . Location: NETHERLANDS , 73 years of age, Patient had the following side effects: cystitis, decreased appetite, diarrhoea, herpes zoster, nausea (What is nausea?), oedema peripheral, pain (What is pain?), palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), THYRAX (View Thyrax Review and Thyrax Label ), SELOKEEN (View Selokeen Review and Selokeen Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ASCAL (View Ascal Review and Ascal Label ), ZOFRAN (View Zofran Review and Zofran Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ).

6097231-4 | Deep Vein Thrombosis, Hepatic Function Abnormal, Oedema Peripheral, Pulmonary Embolism, Pulmonary Oedema
on Feb 19, 2009 Female patient from BELGIUM , 46 years of age, weighting 145.3 lb, was treated with Tyverb (View Usage). After Tyverb was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), hepatic function abnormal, oedema peripheral, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema. Tyverb dosage: 250mg Five Times Per Day. During the same period patient was treated with XELODA (3500mg Per Day) (View Xeloda Review and Xeloda Label ), MEDROL (16mg Per Day) (View Medrol Review and Medrol Label ), ZOMETA (View Zometa Review and Zometa Label ).

6077330-3 | Pain, Rash Maculo-papular
on Feb 05, 2009 Female patient from FRANCE , 44 years of age, was treated with Tyverb (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?), rash maculo-papular. Tyverb dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), FLAGYL (View Flagyl Review and Flagyl Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), MORPHINE (View Morphine Review and Morphine Label ), TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), LANTUS (View Lantus Review and Lantus Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

6068682-9 | Blood Bilirubin Increased, Hepatocellular Injury, Jaundice
Patient was taking Tyverb (View Usage). Patient had the following side effects: blood bilirubin increased, hepatocellular injury, jaundice (What is jaundice?) on Jan 27, 2009 from FRANCE Additional patient health information: Female patient , 53 years of age, . Tyverb dosage: 1250mg Per Day. During the same period patient was treated with XELODA (2000mgm2 Per Day) (View Xeloda Review and Xeloda Label ).